Project Grant R01MH140602
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will provide $600,000 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a next-generation 3 Tesla human MRI scanner for mental health research. The new MRI system will replace an obsolete 16-year-old scanner and integrate with MGH's existing PET-MRI facility at the Athinoula A. Martinos Center for Biomedical Imaging. The...
- This $5.1 million project grant from the National Institute of Mental Health (NIMH), part of the Department of Health and Human Services, supports research under the Mental Health Research Grants program (CFDA 93.242). The Massachusetts General Hospital will utilize its existing biobank of over 800 maternal blood and neonatal cord blood samples linked to clinical records to characterize the impact of maternal SARS-CoV-2 infection on fetal neurodevelopment. Researchers will analyze immune...
- This federal Project Grant award, valued at $1,461,016.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant supports research to evaluate the effect of network-based real-time neurofeedback on mindfulness practice for reducing repetitive negative thinking in adolescents at risk for serious mental illness. The grantee, The General Hospital Corporation (dba Massachusetts General Hospital), will develop and...
- This federal Project Grant award, titled "Fingerprinting Spatiotemporal Patterns of Brain Maturation with Combined Diffusion-Relaxometry Microstructure Imaging," is funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The $134,730 award, effective August 1, 2025, supports research at The General Hospital Corporation, doing business as...
- The National Institute of Mental Health (NIMH) awarded a $206,250 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "A COPY NUMBER VARIANT DISCOVERY PIPELINE FOR INTEGRATED GENOME-EXOME SEQUENCING". The award period runs from Sep 1, 2025 to Aug 31, 2027. The project aims to develop a pipeline to detect copy number variants (CNVs) across the genome and...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $372,307 Project Grant award from the U.S. Department of Health and Human Services' Fogarty International Center (CFDA 93.989 - International Research and Research Training) on September 9, 2025. The grant supports a collaborative project with the Ignace Hospital in Guinea and three rural Guinea sites to build capacity for the diagnosis and treatment of neuromyelitis optica (NMO) using...
- The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865) aims to develop a non-invasive bioimaging tool to track antiretroviral-induced neurodevelopmental adverse events during gestation in a rodent model. The $844,250 award to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) division...
- The National Institute of Mental Health (NIMH) awarded a $156,656 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The General Hospital Corporation (doing business as Massachusetts General Hospital) to advance functional MRI (fMRI) techniques for mapping brain activity across cerebral cortical layers. The project aims to validate and benchmark a "linescan fMRI" method that can achieve higher spatial resolution than conventional laminar fMRI, enabling...
- This $691,935 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders supports research to develop quantitative diffusion MRI methods for predicting neurodevelopmental outcomes in infants with hypoxic ischemic brain injury. The project aims to analyze diffusion MRI data from two large datasets - the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL)...
This $668,311 Project Grant was awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. The grant aims to use advanced brain ultrasound imaging, microcirculation, and parenchymal stiffness assessments to study the potential mechanisms underlying early neurodevelopmental disparities between infants who are HIV-exposed but uninfected (HEU) compared to those who are HIV-unexposed (HU). The research seeks to identify early-life predictors of poorer developmental and neurocognitive outcomes in HEU infants in order to enable earlier interventions. The grant has an award period from September 1, 2025 to May 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $242.3k | 9/5/25 | ||
| Not listed | $426.0k | 9/2/25 |